Table 5 Acute and late treatment-related toxicity
From: Evaluation of particle radiotherapy for the re-irradiation of recurrent intracranial meningioma
Acute treatment-related toxicity | Late treatment-related toxicity | |||||||
|---|---|---|---|---|---|---|---|---|
Side effect | low grade (CTCAE I-II) | high grade (CTCAE III or higher) | low grade (CTCAE I-II) | high grade (CTCAE III or higher) | ||||
n= | % | n= | % | n= | % | n= | % | |
focal alopecia | 14 | 33,3% | 0 | 0,0% | 1 | 2,4% | 0 | 0,0% |
fatigue | 11 | 26,2% | 0 | 0,0% | 4 | 9,5% | 0 | 0,0% |
skin irritation | 10 | 23,8% | 0 | 0,0% | 1 | 2,4% | 0 | 0,0% |
headache | 7 | 16,7% | 0 | 0,0% | 2 | 4,8% | 0 | 0,0% |
nausea | 7 | 16,7% | 0 | 0,0% | 2 | 4,8% | 0 | 0,0% |
lymphedema | 3 | 7,1% | 0 | 0,0% | 0 | 0,0% | 0 | 0,0% |
mucositis | 3 | 7,1% | 0 | 0,0% | 0 | 0,0% | 0 | 0,0% |
xerostomia | 2 | 4,8% | 0 | 0,0% | 3 | 7,1% | 0 | 0,0% |
facial pain | 1 | 2,4% | 0 | 0,0% | 2 | 4,8% | 0 | 0,0% |
radionecrosis | 1 | 2,4% | 2 | 4,8% | 0 | 0,0% | 0 | 0,0% |
dysgeusia | 1 | 2,4% | 0 | 0,0% | 0 | 0,0% | 0 | 0,0% |